BioNTech SE Announces CSO Ryan Richardson's Departure
Ticker: BNTX · Form: 6-K · Filed: Jul 17, 2025 · CIK: 1776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, management-change, 6-K
Related Tickers: BNTX
TL;DR
BNTX CSO Ryan Richardson is out, effective July 17, 2025. Watch for strategic shifts.
AI Summary
On July 17, 2025, BioNTech SE announced that Ryan Richardson will be stepping down from his role as Chief Strategy Officer. The company filed a Form 6-K to report this change.
Why It Matters
The departure of a Chief Strategy Officer can signal shifts in a company's strategic direction or operational focus, potentially impacting future growth and partnerships.
Risk Assessment
Risk Level: low — This filing is a routine announcement of an executive departure and does not contain information about financial performance or significant operational changes.
Key Players & Entities
- BioNTech SE (company) — Registrant
- Ryan Richardson (person) — Chief Strategy Officer
- July 17, 2025 (date) — Announcement Date
- 001-39081 (company) — SEC File Number
- Nasdaq: BNTX (company) — Stock Ticker
FAQ
Who is stepping down from BioNTech SE?
Ryan Richardson is stepping down from his role as Chief Strategy Officer.
What is the effective date of Ryan Richardson's departure?
The announcement was made on July 17, 2025, indicating his departure is effective on or around this date.
What type of SEC filing is this?
This is a Form 6-K filing.
What is BioNTech SE's stock ticker?
BioNTech SE's stock ticker is BNTX on Nasdaq.
What is the address of BioNTech SE's principal executive offices?
The address is An der Goldgrube 12, D-55131 Mainz, Germany.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 by Ryan Richardson regarding BioNTech SE (BNTX).